NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/29/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,975.15 mln
Float136 mln
Earnings Date08/06/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.38
Borderline
1-Year Forecast
23.67
Transformational upside
Relative Strength
86
/ 100
Strongly outperforming
Debt / Equity
0.05
Debt-free
ROE
-42.56
Deeply negative
Business Description
Relay Therapeutics is a Cambridge, Massachusetts-based clinical-stage company focused on discovering new drugs to treat certain cancers and genetic diseases. Its main drug candidates target breast cancer, solid tumors, vascular malformations, and Fabry disease, with additional programs aimed at key cancer-driving proteins. The company works with partners including Pfizer, Elevar Therapeutics, and D. E. Shaw Research, using advanced computer modeling of protein behavior to guide its drug development efforts.
